The U.S. Food and Drug Administration (FDA) has released a new final Compliance Policy Guide on scombrotoxin (histamine) adulteration in fish and fishery products, and has lowered the acceptable levels for histamine in fish.
The guide is intended to assist FDA in addressing adulteration associated with decomposition and histamine identified during surveillance sampling and testing. It also will increase consumer protections related to scombrotoxin fish poisoning by lowering the levels of histamine in fish at which the FDA indicates that it may take action.